Type 1 Diabetes: LY3938577 Study

We are assessing a new medication to see how safe it is and how it works in people with type 1 diabetes and healthy participants. This study may help us understand its potential benefits for managing diabetes.

6-12 monthsSafety phase (I)DiabetologyEndocrinology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
PROFIL Institut fuer Stoffwechselforschung GmbH
Neuss, Germany
Sponsor: Eli Lilly & Co.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.